BioPheresis
Heidelberg
About BioPheresis
BioPheresis Technologies is a US Delaware corporation, and its wholly owned operating company, BioPheresis GmbH, incorporated in 2003, is located in Heidelberg, Germany. BioPheresis has developed a new patent protected blood treatment system designed to remove specific cancer-protecting immune-inhibitors from the blood.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $8.0M
- Funding stage: Early Stage Venture
- Last round: Series A (May 2005)
- Website: biopheresis.de
- Phone: +49 6221-618-9101
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/biopheresis-1959310 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.